Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Current Signal: SELL (auto-tracking)
-0.49% $12.15
America/New_York / 17 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 5 106.40 mill |
EPS: | 0.0100 |
P/E: | 1 215.00 |
Earnings Date: | Feb 14, 2024 |
SharesOutstanding: | 420.28 mill |
Avg Daily Volume: | 3.75 mill |
RATING 2024-04-17 |
---|
A+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Buy | |
DE: | Strong Buy | |
P/E: | Strong Buy | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 1 215.00 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 1 215.00 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
$8.98 (-26.10%) $-3.17 |
Date: 2024-04-17 |
Expected Trading Range (DAY) |
---|
$ 11.72 - 12.58 ( +/- 3.56%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-27 | Flanagan Joseph Gerard | Buy | 148 849 | Common Stock |
2024-02-27 | Flanagan Joseph Gerard | Sell | 55 825 | Common Stock |
2024-03-11 | Sparby John M. | Sell | 3 101 | Common Stock |
2024-03-06 | Sparby John M. | Sell | 3 750 | Common Stock |
2024-03-07 | Sparby John M. | Sell | 10 046 | Common Stock |
INSIDER POWER |
---|
-60.53 |
Last 88 transactions |
Buy: 2 022 016 | Sell: 17 306 828 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $12.15 (-0.49% ) |
Volume | 1.231 mill |
Avg. Vol. | 3.75 mill |
% of Avg. Vol | 32.82 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $10.54 | N/A | Active |
---|
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.